Skip to main content

Table 2 Comparison of positive rate of nine autoantibodies between non-AIP CP patients and historial healthy controls

From: Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients

Autoantibody

non-AIP CP patients

Historial Healthy controls

P

Positive

Negative

Frequency (%)

Positive

Negative

Frequency (%)

Anti-β2-glycoprotein I antibody

51

506

9.16

37

1839

1.97

< 0.001

Anti-smooth muscle antibody

17

540

3.05

24

302

7.36

0.003

Anticardiolipin antibody

16

541

2.87

93

1431

6.10

0.003

Anti-mitochondrial antibody

9

548

1.62

14

1340

1.03

0.224

Anti SS-B antibody

9

548

1.62

4

1659

0.24

< 0.001

Anti-double-stranded DNA antibody

8

549

1.44

0

202

0

0.190

Anti-single-stranded DNA antibody

6

551

1.08

14

568

2.41

0.088

Anti-histone antibody

5

552

0.90

14

711

1.93

0.129

Anti-ribonucleoprotein antibody

3

554

0.54

13

1078

1.19

0.201

Anti-proteinase 3 IgG antibody

3

554

0.54

0

237

0

0.558

Anti-PM-Scl antibody

2

555

0.36

Anti-neutrophil cytoplasmic antibody

2

555

0.36

Anti-ribosomal antibody

2

555

0.36

Anti SS-A antibody

1

556

0.18

Anti-Jo-1 antibody

1

556

0.18

Anti-SM antibody

1

556

0.18

Anti-myeloperoxidase antibody

1

556

0.18

anti-neutrophil perinuclear antibody

1

556

0.18

Anti-proliferating cell nuclear antigen antibody

1

556

0.18

Anti-Scl 70 antibody

0

556

0

Anti-nucleosome antibodies

0

556

0

Anti-glomerular basement membrane antibody

0

556

0

  1. CP Chronic pancreatitis, AIP Autoimmune pancreatitis